
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC284f]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part B--General Provisions Respecting National Research Institutes
 
Sec. 284f. Parkinson's disease


(a) In general

    The Director of NIH shall establish a program for the conduct and 
support of research and training with respect to Parkinson's disease 
(subject to the extent of amounts appropriated under subsection (e) of 
this section).

(b) Inter-institute coordination

                           (1) In general

        The Director of NIH shall provide for the coordination of the 
    program established under subsection (a) of this section among all 
    of the national research institutes conducting Parkinson's disease 
    research.

                           (2) Conference

        Coordination under paragraph (1) shall include the convening of 
    a research planning conference not less frequently than once every 2 
    years. Each such conference shall prepare and submit to the 
    Committee on Appropriations and the Committee on Labor and Human 
    Resources of the Senate and the Committee on Appropriations and the 
    Committee on Commerce of the House of Representatives a report 
    concerning the conference.

(c) Morris K. Udall research centers

                           (1) In general

        The Director of NIH is authorized to award Core Center Grants to 
    encourage the development of innovative multidisciplinary research 
    and provide training concerning Parkinson's disease. The Director is 
    authorized to award not more than 10 Core Center Grants and 
    designate each center funded under such grants as a Morris K. Udall 
    Center for Research on Parkinson's Disease.

                          (2) Requirements

        (A) In general

            With respect to Parkinson's disease, each center assisted 
        under this subsection shall--
                (i) use the facilities of a single institution or a 
            consortium of cooperating institutions, and meet such 
            qualifications as may be prescribed by the Director of the 
            NIH; and
                (ii) conduct basic and clinical research.

        (B) Discretionary requirements

            With respect to Parkinson's disease, each center assisted 
        under this subsection may--
                (i) conduct training programs for scientists and health 
            professionals;
                (ii) conduct programs to provide information and 
            continuing education to health professionals;
                (iii) conduct programs for the dissemination of 
            information to the public;
                (iv) separately or in collaboration with other centers, 
            establish a nationwide data system derived from patient 
            populations with Parkinson's disease, and where possible, 
            comparing relevant data involving general populations;
                (v) separately or in collaboration with other centers, 
            establish a Parkinson's Disease Information Clearinghouse to 
            facilitate and enhance knowledge and understanding of 
            Parkinson's disease; and
                (vi) separately or in collaboration with other centers, 
            establish a national education program that fosters a 
            national focus on Parkinson's disease and the care of those 
            with Parkinson's disease.

              (3) Stipends regarding training programs

        A center may use funds provided under paragraph (1) to provide 
    stipends for scientists and health professionals enrolled in 
    training programs under paragraph (2)(B).

                       (4) Duration of support

        Support of a center under this subsection may be for a period 
    not exceeding five years. Such period may be extended by the 
    Director of NIH for one or more additional periods of not more than 
    five years if the operations of such center have been reviewed by an 
    appropriate technical and scientific peer review group established 
    by the Director and if such group has recommended to the Director 
    that such period should be extended.

(d) Morris K. Udall Awards for Excellence in Parkinson's Disease 
        Research

    The Director of NIH is authorized to establish a grant program to 
support investigators with a proven record of excellence and innovation 
in Parkinson's disease research and who demonstrate potential for 
significant future breakthroughs in the understanding of the 
pathogensis,\1\ diagnosis, and treatment of Parkinson's disease. Grants 
under this subsection shall be available for a period of not to exceed 5 
years.
---------------------------------------------------------------------------
    \1\ So in original. Probably should be ``pathogenesis,''.
---------------------------------------------------------------------------

(e) Authorization of appropriations

    For the purpose of carrying out this section and section 241 of this 
title and this subchapter with respect to research focused on 
Parkinson's disease, there are authorized to be appropriated up to 
$100,000,000 for fiscal year 1998, and such sums as may be necessary for 
each of the fiscal years 1999 and 2000.

(July 1, 1944, ch. 373, title IV, Sec. 409B, as added Pub. L. 105-78, 
title VI, Sec. 603(c), Nov. 13, 1997, 111 Stat. 1520.)


                           Finding and Purpose

    Section 603(b) of Pub. L. 105-78 provided that:
    ``(1) Finding.--Congress finds that to take full advantage of the 
tremendous potential for finding a cure or effective treatment, the 
Federal investment in Parkinson's disease must be expanded, as well as 
the coordination strengthened among the National Institutes of Health 
research institutes.
    ``(2) Purpose.--It is the purpose of this section [enacting this 
section] to provide for the expansion and coordination of research 
regarding Parkinson's disease, and to improve care and assistance for 
afflicted individuals and their family caregivers.''
